Chicago Capital, LLC Eli Lilly & CO Transaction History

Chicago Capital, LLC

$3.51 Billion
Q1 2025

A detailed history of Chicago Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chicago Capital, LLC holds 85,631 shares of LLY stock, worth $68.1 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

85,631

Previous 38,522 122.29%

Holding current value

$68.1 Million

Previous $29.7 Million 137.82%

% of portfolio

2.02%

Previous 0.8%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$725.72 - $929.72 $34.2 Million - $43.8 Million	47,109 Added 122.29%	85,631 $70.7 Million
Q4 2024 Jan 24, 2025	BUY	$727.2 - $932.06 $8.51 Million - $10.9 Million	11,709 Added 43.67%	38,522 $29.7 Million
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $86,479 - $107,522	-112 Reduced 0.42%	26,813 $23.8 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $46,391 - $58,178	64 Added 0.24%	26,925 $24.4 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $394,405 - $527,658	666 Added 2.54%	26,861 $20.9 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $3.17 Million - $3.74 Million	6,040 Added 29.97%	26,195 $15.3 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $503,817 - $694,588	-1,159 Reduced 5.44%	20,155 $10.8 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $213,951 - $286,077	-610 Reduced 2.78%	21,314 $10 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $39,139 - $45,967	126 Added 0.58%	21,924 $7.53 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $9,646 - $11,240	-30 Reduced 0.14%	21,798 $0
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $13,936 - $16,363	50 Added 0.23%	21,828 $7.08 Million
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $12,141 - $15,068	-54 Reduced 0.25%	21,778 $6.02 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $89,913 - $116,302	498 Added 2.33%	21,832 $5.01 Million
Q1 2021 Apr 13, 2021	BUY	$164.32 - $212.72 $14,295 - $18,506	87 Added 0.41%	21,334 $3.99 Million
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $1,304 - $1,726	-10 Reduced 0.05%	21,247 $3.59 Million
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $296,434 - $366,901	-2,490 Reduced 10.49%	21,257 $2.95 Million
Q4 2019 Jan 14, 2020	SELL	$106.92 - $132.43 $10,692 - $13,243	-100 Reduced 0.42%	23,747 $3.12 Million
Q2 2019 Jul 11, 2019	BUY	$110.79 - $129.32 $110,790 - $129,320	1,000 Added 4.38%	23,847 $2.64 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $91,496 - $107,698	-822 Reduced 3.47%	22,847 $2.97 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $21,180 - $23,728	200 Added 0.85%	23,669 $2.74 Million
Q2 2018 Jul 19, 2018	BUY	$75.7 - $86.88 $53,368 - $61,250	705 Added 3.1%	23,469 $2 Million
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $1.69 Million - $1.99 Million	22,764 New	22,764 $1.76 Million

Others Institutions Holding LLY

# of Institutions

4,395

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Eli Lilly & CO Transaction History